Durata Therapeutics DRTX
Last Post: 11/18/2014 10:27:55 AM
Board Marks: 0
Posts Today: 0
Board Views Today: 17
Durata Therapeutics (NASDAQ: DRTX)
Durata Therapeutics is a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses. Durata has completed two global Phase 3 clinical trials with its lead product candidate, dalbavancin, under investigation for the treatment of patients with acute bacterial skin and skin structure infections caused by susceptible gram-positive bacteria.
Company Website: http://www.duratatherapeutics.com/
Durata Therapeutics is a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses. Durata has completed two global Phase 3 clinical trials with its lead product candidate, dalbavancin, under investigation for the treatment of patients with acute bacterial skin and skin structure infections caused by susceptible gram-positive bacteria.
Company Website: http://www.duratatherapeutics.com/
Durata Therapeutics (NASDAQ: DRTX) Stock Message Board
Post
Subject
Author
Posted On
| 7 | DRTX 24.16 Durata Therapeutics Inc $DRTX added to | clayton | 11/18/2014 10:27:55 AM |
| 6 | DRTX Year to date has changed +88.90% percent. | Jake13 | 11/18/2014 12:54:15 AM |
| 5 | DRTX 24.16 Durata Therapeutics Inc Stock Charts | chartguy89 | 11/18/2014 12:51:52 AM |
| 4 | DRTX 24.12 Durata Therapeutics Inc Stock Charts | chartguy89 | 11/11/2014 3:08:48 AM |
| 3 | DRTX Year to date has changed +88.58% percent. | Jake13 | 11/11/2014 1:52:36 AM |
| 2 | $DRTX cl | PoemStone | 05/23/2014 8:50:22 PM |
| 1 | Durata Therapeutics, Inc. (DRTX) A skin and skin | riddock57 | 04/01/2014 3:25:45 AM |